🟢 Tenax Therapeutics is trading 5% up today despite no clear catalyst

Tenax Therapeutics is trading 5.36% up at $1.84, with no clear catalyst identified.

• No major August 24, 2026 company announcement or clearly attributed catalyst was identified.
• The latest significant event was the August 10 Phase 3 LEVEL trial failure, which previously pressured shares sharply.
• Broader markets are mixed rather than strongly positive, so today’s gain may reflect volatility or trading activity.